Earnings Per Share
Continuing operations (in dollars per share)
Edwards Lifesciences Continuing operations (in dollars per share) increased by 500.0% to $0.66 in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 6.5%, from $0.62 to $0.66. Over 3 years (FY 2022 to FY 2025), Continuing operations (in dollars per share) shows a downward trend with a -5.4% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementIncome Statement
SectionEarnings Per Share
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2022
Last reportedQ1 2026May 6, 2026
How to read this metric
An increase suggests improved profitability per share, which is a key driver of stock price performance.
Detailed definition
This metric measures the portion of a company's profit from continuing operations allocated to each outstanding share of...
Peer comparison
Standardized metric used by investors to compare valuation and earnings power across all public companies.
Metric ID:
eps_income_loss_from_continuing_operations_per_basic_shareHistorical Data
17 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.54 | $0.54 | $0.54 | $0.54 | $0.49 | $0.42 | $0.55 | $0.55 | $0.54 | $0.61 | $0.61 | $0.58 | $0.62 | $0.58 | $0.50 | $0.11 | $0.66 |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -8.4% | -14.3% | +31.0% | +0.0% | -1.8% | +13.0% | +0.0% | -4.9% | +6.9% | -6.5% | -13.8% | -78.0% | +500.0% |
| YoY Change | — | — | — | — | -8.4% | -21.5% | +2.8% | +2.8% | +10.2% | +45.2% | +10.9% | +5.5% | +14.8% | -4.9% | -18.0% | -81.0% | +6.5% |
Range$0.11 – $0.66
CAGR+5.4%
Avg YoY Growth-2.7%
Median YoY Growth+2.8%
Continuing operations (in dollars per share) at Other Companies
Frequently Asked Questions
- What is Edwards Lifesciences's continuing operations (in dollars per share)?
- Edwards Lifesciences (EW) reported continuing operations (in dollars per share) of $0.66 in Q1 2026.
- How has Edwards Lifesciences's continuing operations (in dollars per share) changed year-over-year?
- Edwards Lifesciences's continuing operations (in dollars per share) increased by 6.5% year-over-year, from $0.62 to $0.66.
- What is the long-term trend for Edwards Lifesciences's continuing operations (in dollars per share)?
- Over 3 years (2022 to 2025), Edwards Lifesciences's continuing operations (in dollars per share) has grown at a -5.4% compound annual growth rate (CAGR), from $2.14 to $1.81.
- What does continuing operations (in dollars per share) mean?
- The profit earned from ongoing business activities for each share of stock.